Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Pluda

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|April 1, 1997
Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategiesJ M Pluda
Cancer|August 1, 1996
Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreasJ M Pluda, D R Parkinson
Investigational New Drugs|January 1, 1997
Development of angiogenesis inhibitors for cancer therapyS G Eckhardt, J M Pluda
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
The occurrence of opportunistic non-Hodgkin's lymphomas in the setting of infection with the human immunodeficiency virusJ M Pluda, R Yarchoan, S Broder
Hematology/Oncology Clinics of North America|April 1, 1991
Hematologic effects of AIDS therapiesJ M Pluda, H Mitsuya, R Yarchoan
Hematology/Oncology Clinics of North America|October 1, 1996
AIDS-related Kaposi's sarcoma. A template for the translation of molecular pathogenesis into targeted therapeutic approachesJ E Karp, J M Pluda, R Yarchoan
Oncology (Williston Park, N.Y.)|June 30, 1998
The challenge of designing clinical trials for AIDS-related Kaposi's sarcomaR F Little, J M Pluda, E Feigal, et al.
Oncology (Williston Park, N.Y.)|December 1, 1993
Noncytotoxic approaches to the treatment of HIV-associated Kaposi's sarcomaJ M Pluda, D R Parkinson, E Feigal, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
Clinical development of anticancer agents from natural productsD R Parkinson, S G Arbuck, T Moore, et al.
Seminars in Oncology|December 12, 2001
Approaches to preclinical screening of antiangiogenic agentsE A Kruger, P H Duray, D K Price, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|April 1, 1997
Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategiesJ M Pluda
Cancer|August 1, 1996
Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreasJ M Pluda, D R Parkinson
Investigational New Drugs|January 1, 1997
Development of angiogenesis inhibitors for cancer therapyS G Eckhardt, J M Pluda
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
The occurrence of opportunistic non-Hodgkin's lymphomas in the setting of infection with the human immunodeficiency virusJ M Pluda, R Yarchoan, S Broder
Hematology/Oncology Clinics of North America|April 1, 1991
Hematologic effects of AIDS therapiesJ M Pluda, H Mitsuya, R Yarchoan
Hematology/Oncology Clinics of North America|October 1, 1996
AIDS-related Kaposi's sarcoma. A template for the translation of molecular pathogenesis into targeted therapeutic approachesJ E Karp, J M Pluda, R Yarchoan
Oncology (Williston Park, N.Y.)|June 30, 1998
The challenge of designing clinical trials for AIDS-related Kaposi's sarcomaR F Little, J M Pluda, E Feigal, et al.
Oncology (Williston Park, N.Y.)|December 1, 1993
Noncytotoxic approaches to the treatment of HIV-associated Kaposi's sarcomaJ M Pluda, D R Parkinson, E Feigal, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
Clinical development of anticancer agents from natural productsD R Parkinson, S G Arbuck, T Moore, et al.
Seminars in Oncology|December 12, 2001
Approaches to preclinical screening of antiangiogenic agentsE A Kruger, P H Duray, D K Price, et al.
Pageof 6